mRNA Flu Vaccine for Flu
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu season. The study will measure prevention of laboratory-confirmed flu illness, side effects, and immune responses.
Are You a Good Fit for This Trial?
This trial is for adults aged 65 and older who are generally healthy or have stable chronic conditions. Participants must be able to follow study instructions, give consent, and not have had recent major changes in their health.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Licensed Influenza Vaccine
- mRNA Seasonal Flu vaccine
Trial Overview
The study compares a new mRNA flu vaccine with an already approved flu vaccine. Each participant gets one shot and is monitored through the flu season to see how well each vaccine prevents the flu and what side effects occur.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive a single dose of investigational mRNA Seasonal Flu vaccine on Day 1.
Participants will receive a single dose of an age-appropriate and season-adapted licensed influenza vaccine Day 1.
Find a Clinic Near You
Who Is Running the Clinical Trial?
GlaxoSmithKline
Lead Sponsor
Dame Emma Walmsley
GlaxoSmithKline
Chief Executive Officer since 2017
MA in Classics and Modern Languages from Oxford University
Dr. Hal Barron
GlaxoSmithKline
Chief Medical Officer since 2018
MD from Harvard Medical School
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.